Nirland Ltd - Sep 30, 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
10%+ Owner
Signature
Nirland Limited, By: /s/ David Rowland, Director
Stock symbol
CDT
Transactions as of
Sep 30, 2024
Transactions value $
-$297,644
Form type
4
Date filed
10/2/2024, 05:02 PM
Previous filing
Aug 13, 2024
Next filing
Oct 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDT Common Stock, par value $0.0001 per share Sale -$122K -1.02M -8.13% $0.12 11.5M Sep 30, 2024 Direct F1
transaction CDT Common Stock, par value $0.0001 per share Sale -$141K -1.25M -10.89% $0.11 10.2M Oct 1, 2024 Direct F1
transaction CDT Common Stock, par value $0.0001 per share Sale -$34.3K -333K -3.26% $0.10 9.9M Oct 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Nirland Limited, a company registered in Guernsey with company number 58804 of The Old Stables Rue a L'Or, St Peter Port, GUERNSEY GY1 1QG ("Nirland Limited") is wholly owned by Stockton Limited, a company registered in Guernsey ("Stockton Limited"), which is wholly owned by The Rowland Master Trust, a Guernsey trust ("The Rowland Master Trust"). Dovet Limited, a company registered in Guernsey ("Dovet Limited"), is the sole trustee of The Rowland Master Trust. By virtue of these relationships, each of Stockton Limited, The Rowland Master Trust and Dovet Limited may be deemed to share beneficial ownership of the securities held of record by Nirland Limited.